Hepatogastroenterology. 2009;56(94-95):1304-9.
Age as a clinical predictor of relapse after induction therapy in ulcerative colitis.
제1저자 장은선 · 교신저자 이동호
소속 (1)
- Department of Internal Medicine, Seoul National University Bundang Hospital, Gumi-dong 300, Bundang-gu, Seongnam-si, Republic of Korea.
Abstract
BACKGROUND/AIMS Whether older patients with ulcerative colitis (UC) have a better clinical course than younger patients is unclear. We compared the clinical characteristics between older and younger age groups in South Korea to elucidate the impact of age on relapse in UC.
METHODOLOGY Patients between 18 and 85 years old who were diagnosed with UC at Seoul National University Bundang Hospital between 1 May 2003 and 31 Oct 2007 were enrolled. It was reviewed their symptoms, endoscopic and pathologic findings, and drugs used in induction treatment.
RESULTS Of the 73 patients with UC who achieved remission after induction treatment, 38 relapsed. The patients aged 18-44 and 45-85 years had similar clinical features, but the relapse rate was significantly higher in the younger group (69.2 vs. 32.4%; p = 0.002). In a multivariable analysis, age 45-85 years old was an independent protective factor against relapse (OR, 0.146; 95% CI, 0.035-0.508; p = 0.003) after adjusting for sex, frequency of diarrhea, hematochezia grade, disease extent, and systemic steroid used in induction treatment.
CONCLUSION An age of 45 years or older is an independent predictor of less relapse in UC.
그 밖의 정보
- 출판 형태
- Journal Article
- 저널
- Hepato-gastroenterology · ISSN 0172-6390
- MeSH
- Adolescent · Adult · Age Factors · Aged · Aged, 80 and over · Colitis, Ulcerative / drug therapy · Female · Follow-Up Studies · Humans · Male · Middle Aged · Multivariate Analysis · Recurrence · Retrospective Studies